EMA’s 2023 new medicines report suggests return to pre-pandemic volume

This week, the EMA released its 2023 New Medicines Highlights report, providing insights into the number of opinions provided and the types of products reviewed. Here AgencyIQ analyzes this new report against those from previous years, identifying notable changes in the total number and types of reviews, with an apparent return to pre-pandemic volume.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap